Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit

The NIH Virtual SARS-CoV-2 Antiviral Summit, held on 6 November 2020, was organized to provide an overview on the status and challenges in developing antiviral therapeutics for coronavirus disease 2019 (COVID-19), including combinations of antivirals. Scientific experts from the public and private s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Matthew D, Anderson, James M, Anderson, Annaliesa, Baker, David, Bradner, Jay, Brimacombe, Kyle R, Campbell, Elizabeth A, Corbett, Kizzmekia S, Carter, Kara, Cherry, Sara, Chiang, Lillian, Cihlar, Tomas, de Wit, Emmie, Denison, Mark, Disney, Matthew, Fletcher, Courtney V, Ford-Scheimer, Stephanie L, Götte, Matthias, Grossman, Abigail C, Hayden, Frederick G, Hazuda, Daria J, Lanteri, Charlotte A, Marston, Hilary, Mesecar, Andrew D, Moore, Stephanie, Nwankwo, Jennifer O, O’Rear, Jules, Painter, George, Singh Saikatendu, Kumar, Schiffer, Celia A, Sheahan, Timothy P, Shi, Pei-Yong, Smyth, Hugh D, Sofia, Michael J, Weetall, Marla, Weller, Sandra K, Whitley, Richard, Fauci, Anthony S, Austin, Christopher P, Collins, Francis S, Conley, Anthony J, Davis, Mindy I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
NIH Virtual SARS-CoV-2 Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280938/
https://www.ncbi.nlm.nih.gov/pubmed/34111271
http://dx.doi.org/10.1093/infdis/jiab305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280938/
https://www.ncbi.nlm.nih.gov/pubmed/34111271
http://dx.doi.org/10.1093/infdis/jiab305

Ejemplares similares